HEMAFER (Ferric Hydroxide Polymaltose Complex)

Product description

INDICATIONS: Iron deficiency of any cause and iron deficiencies without anaemia.

CHEWABLE TABLETS: 100mg Iron(III)/tablet (BT x 30 chew. tabl.)(BT x 50 chew. tabl.)(BT x 100 chew. tall.)ORAL SOLUTION SINGLE DOSE: 100mg Iron(III)/5ml (BT x 10 vials)
SYRUP: 50mg Iron(III)/5ml (Bottle of 125ml)
DROPS ORAL SOLUTION: 50mg Iron(III)/ml (Bottle of 30ml)
INJECTABLE SOLUTION: 332 (100Fe+++)mg Iron hydroxide polymaltose complex/2ml (BT x 5 amps x 2 ml)
EFFERVESCENT TABLETS: 357 (100Fe+++)mg Iron hydroxide polymaltose complex/eff. tablet (BT x 12 eff. tabl.)(BT x 28 eff. tabl.)(Tube of 10 eff. tabl.)
Read more

Specifications

Categories Finished Dosage Forms
Sales markets Middle East Region (e.g. UAE); Africa; Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries)
Supplied from Greece

More products from Uni-Pharma SA

View all our products (45)
HEMAFER (Ferric Hydroxide Polymaltose Complex)

Contact information

Address

Telephone

Website

View all contact information
Grifols Partnership- Contract Manufacturing Services

Grifols Partnership- Contract Manufacturing Services

Collaborating to innovate in drug formulation

Collaborating to innovate in drug formulation

API Supplier, CMO, CDMO

API Supplier, CMO, CDMO

Datwyler Pharma Packaging

Datwyler Pharma Packaging

Curia - From Curiosity to Cure

Curia - From Curiosity to Cure